Logos Global Management

Latest statistics and disclosures from Logos Global Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Logos Global Management LP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Logos Global Management

Companies in the Logos Global Management portfolio as of the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alx Oncology Hldgs 15.2 $118M NEW 3.1M 37.74
Keros Therapeutics (KROS) 7.9 $62M +300% 1.6M 38.57
Nkarta 7.9 $62M NEW 2.0M 30.06
Forma Therapeutics Hldgs SHS (FMTX) 7.5 $59M -8% 1.2M 49.84
Global Blood Therapeutics In (GBT) 6.0 $47M +529% 850k 55.14
Tg Therapeutics (TGTX) 6.0 $47M +105% 1.8M 26.76
Sarepta Therapeutics (SRPT) 4.9 $39M NEW 275k 140.43
Dyne Therapeutics 4.1 $32M NEW 1.6M 20.19
Repare Therapeutics Ord (RPTX) 3.8 $30M +46% 977k 30.77
Bioxcel Therapeutics (BTAI) 3.1 $24M +83% 550k 43.36
Avidity Biosciences Ord (RNA) 2.6 $20M -22% 722k 28.15
Athira Pharma 2.4 $19M NEW 1.0M 18.46
Celldex Therapeutics Com New (CLDX) 2.3 $18M -40% 1.2M 14.83
Compass Pathways Sponsored Ads 2.2 $18M NEW 500k 34.90

Setup an alert

Logos Global Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Cytokinetics Com New (CYTK) 2.1 $16M -6% 750k 21.65
Sage Therapeutics (SAGE) 2.0 $15M NEW 250k 61.12
Calliditas Therapeutics Ab Sponsered Ads (CALT) 1.7 $13M +83% 550k 24.00
Bristol-myers Squibb Right 99/99/9999 (BMY.R) 1.6 $12M +37% 5.5M 2.25
Kymera Therapeutics 1.2 $9.7M NEW 301k 32.31
Nurix Therapeutics 1.2 $9.6M NEW 275k 34.91
Harmony Biosciences Hldgs In 1.2 $9.3M NEW 275k 33.90
Iteos Therapeutics 0.9 $7.4M NEW 300k 24.67
Therapeutics Acquisition Cor Com Cl A 0.9 $7.2M NEW 500k 14.38
Akouos (AKUS) 0.9 $7.1M -31% 310k 22.87
Unum Therapeutics Ord (UMRX) 0.8 $6.3M NEW 2.7M 2.34
Inhibrx 0.7 $5.6M NEW 312k 18.00
Lifesci Acquisition Corp Unit 03/31/2025 (LSACU) 0.7 $5.4M 400k 13.60
Pmv Pharmaceuticals 0.7 $5.3M NEW 150k 35.50
Pandion Therapeutics 0.7 $5.2M NEW 450k 11.46
Larimar Therapeutics (LRMR) 0.6 $5.0M +474% 330k 15.17
Outset Med 0.6 $5.0M NEW 100k 50.00
Annexon 0.6 $4.8M NEW 160k 30.23
Passage Bio (PASG) 0.6 $4.5M 344k 13.11
Relay Therapeutics 0.5 $4.3M NEW 100k 42.59
Kalvista Pharmaceuticals (KALV) 0.5 $3.8M -46% 300k 12.59
Black Diamond Therapeutics (BDTX) 0.5 $3.7M 124k 30.23
Inari Medical Ord (NARI) 0.4 $3.5M NEW 50k 69.02
Health Sciences Acq Corp 2 Ord Shs 0.4 $3.3M NEW 300k 11.00
Pliant Therapeutics (PLRX) 0.4 $3.1M -70% 137k 22.65
Panacea Acquisition Corp Unit 99/99/9999 0.3 $2.4M NEW 200k 12.00
Acutus Medical 0.3 $2.2M NEW 75k 29.80
Chardan Healthcr Acqstn 2 Unit 99/99/9999 (CHAQ.U) 0.3 $2.1M 200k 10.55
Bctg Acquisition Corp 0.3 $2.1M NEW 200k 10.36
Fs Dev Corp Com Cl A 0.1 $1.1M NEW 100k 11.20
Arya Sciences Acquistion Unit 06/09/2027 (ARYBU) 0.1 $1.1M 100k 11.00
Rapt Therapeutics (RAPT) 0.1 $1.0M -79% 31k 32.19

Past Filings by Logos Global Management

SEC 13F filings are viewable for Logos Global Management going back to 2019